Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2007-05-15
2007-05-15
McKenzie, Thomas (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S252010, C514S255030, C514S256000, C514S318000, C514S326000, C514S336000, C514S359000, C514S361000, C514S363000, C514S364000, C546S139000, C546S146000, C546S147000, C546S148000, C546S152000, C546S156000, C546S161000, C546S211000, C546S218000, C546S268400, C546S268700, C546S269100, C546S192000, C546S193000, C546S194000, C546S206000, C546S209000, C546S210000, C546S216000, C544S111000, C544S112000, C544S113000, C544S114000, C544S115000, C544S224000, C544S238000, C544S242000, C544S333000, C544S336000, C544S
Reexamination Certificate
active
09451826
ABSTRACT:
Compounds of Formula 1in-line-formulae description="In-line Formulae" end="lead"?[Regionα]−[Regionβ]−[Regionγ]−[Regionδ] (I)in-line-formulae description="In-line Formulae" end="tail"?which are useful as modulators of chemokine activity. The invention also provides pharmaceutical formulations and methods of treatment using these compounds.
REFERENCES:
patent: 5444074 (1995-08-01), Baker et al.
patent: 5489599 (1996-02-01), Carter et al.
patent: 5824650 (1998-10-01), De Lacharriere et al.
patent: 5972892 (1999-10-01), De Lacharriere et al.
patent: 6511994 (2003-01-01), Kim et al.
patent: 6586430 (2003-07-01), Armour et al.
patent: 9311122 (1993-06-01), None
patent: 9831364 (1996-07-01), None
patent: 9825604 (1998-06-01), None
patent: 9825605 (1998-06-01), None
patent: 9825617 (1998-06-01), None
patent: 9904794 (1999-02-01), None
patent: 9909984 (1999-03-01), None
Brown et al, Chem. Abs. vol. 68. No. 105162, “Triazoles” (1968).
Lipinski et al, Chem Abs. vol. 103 No. 160451, “Pseudosymmetry omlbioisasteris in bidryl pydridyl competitive histamine H2-receptor antagonists”.
Armour Duncan Robert
Edwards Martin Paul
Perros Manoussos
Price David Anthony
Stammen Blanda Luzia Christa
Agouron Pharmaceuticals , Inc.
Covington Raymond
Hutchinson Keith D.
McKenzie Thomas
Zielinski Bryan C.
LandOfFree
CCR5 modulators does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with CCR5 modulators, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and CCR5 modulators will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3802854